Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

FDA Approves First Chikungunya Vaccine

Valneva's Ixchiq is the first vaccine for chikungunya, an “emerging global health threat” transmitted by mosquitoes.

Pixabay
Pixabay

According to a recent Fox News article, the FDA has approved the first chikungunya vaccine, called Ixchiq, developed by Valneva. The vaccine is intended for people 18 and older who are at risk of exposure to the chikungunya virus, which is transmitted via mosquitos. Chikungunya is categorized as an "emerging global health threat," with at least five million cases reported in the past 15 years. The virus can cause severe and prolonged health issues, particularly in older adults and those with underlying medical conditions. 

FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
Break out of the ordinary: see what’s new in life sciences packaging